Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre, Open-label, Post-registration Observational Study of Elpida Used in the First Line Therapy for HIV-1 Infected Patients Against the Background of Standard Baseline ART (NNRTIs + 2 NRTIs)

Trial Profile

Multicentre, Open-label, Post-registration Observational Study of Elpida Used in the First Line Therapy for HIV-1 Infected Patients Against the Background of Standard Baseline ART (NNRTIs + 2 NRTIs)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2018

At a glance

  • Drugs Elsulfavirine (Primary) ; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors Viriom
  • Most Recent Events

    • 25 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top